Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Lifecore Biomedical Inc., 3 years.
Lifecore Biomedical Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Lifecore Biomedical Inc. June 4, 2026100.0%
-
Lifecore Biomedical Inc. October 29, 202599.7%
-
Lifecore Biomedical Inc. November 7, 202499.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 4, 2026 | Lifecore Biomedical Inc. | Grant or award | +25,907 | — | — |
| Jul 15, 2025 | Lifecore Biomedical Inc. | Grant or award | +19,506 | — | — |
| Jul 8, 2024 | Lifecore Biomedical Inc. | Grant or award | +30,000 | — | — |
| Feb 1, 2024 | Lifecore Biomedical Inc. | Option exercise | +9,554 | — | — |
| Oct 3, 2023 | Quest Resource Holding Corporation | Open-market purchase | +188 | $7.25 | $1,363 |
| Oct 2, 2023 | Quest Resource Holding Corporation | Open-market purchase | +4,173 | $7.24 | $30,213 |
| Oct 2, 2023 | Quest Resource Holding Corporation | Open-market purchase | +4,381 | $7.24 | $31,718 |
| Sep 8, 2023 | Quest Resource Holding Corporation | Open-market purchase | +1,410 | $7.24 | $10,208 |
| Sep 7, 2023 | Quest Resource Holding Corporation | Open-market purchase | +276 | $7.25 | $2,001 |
| Jun 1, 2023 | Lifecore Biomedical Inc. | Grant or award | +18,182 | — | — |
| May 31, 2023 | Lifecore Biomedical Inc. | Option exercise | +9,474 | — | — |
Questions about Nelson Obus
What boards is Nelson Obus on?
Nelson Obus sits on the board of Lifecore Biomedical Inc.
How long has Nelson Obus served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.